Bioregenx BRGX
OTC BRGX
$0.01 +0.00 (+0.00%)
At close: Sep 21, 2026 · 4:00 PM EDT

Bioregenx (BRGX) Cash from Operations Growth (3y) (2025 - 2026)

Analysis

Bioregenx (BRGX) Cash from Operations Growth (3y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Abbott Laboratories 179.49 Bn 174.54 Bn 7.27 Bn 27.41%
2 Intuitive Surgical 142.30 Bn 137.21 Bn 1.96 Bn 16.81%
3 Medtronic 116.24 Bn 108.04 Bn 6.34 Bn 27.02%
4 Stryker 105.51 Bn 102.03 Bn 4.50 Bn 22.38%
5 Boston Scientific 65.13 Bn 64.83 Bn 3.85 Bn 30.85%
6 Edwards Lifesciences 51.20 Bn 47.05 Bn 1.35 Bn 168.71%
7 Dexcom 33.79 Bn 31.84 Bn 830.00 Mn 12.26%
8 Resmed 32.01 Bn 30.54 Bn 861.22 Mn 24.18%
9 Alcon 31.98 Bn 30.52 Bn 1.68 Bn 16.21%
10 Bioregenx 9.72 Mn 9.67 Mn 348,288.00 27.63%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 27.63%
Dec 31, 2025 161.86%
Sep 30, 2025 -125.30%
Jun 30, 2025 27.99%
Mar 31, 2025 56.07%
API Access

Bioregenx Cash from Operations Growth (3y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations-growth-3y&ticker=BRGX&period=max&api_key=YOUR_API_KEY